Related Experiment Video
Updated: Jun 29, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
[Posterior reversible leukoencephalopathy in a patient with postpartum eclampsia]
B Domínguez-Fuentes1, D García-Gil, A Romero-Palacios
1Servicio de Medicina Interna. Hospital Universitario Puerto Real. Cádiz. España.
Postpartum reversible posterior leukoencephalopathy syndrome (RPLS) can occur without hypertension. Early diagnosis and aggressive treatment are crucial for favorable outcomes in women with postpartum neurological symptoms.
Area of Science:
- Neurology
- Radiology
- Obstetrics
Background:
- Reversible posterior leukoencephalopathy syndrome (RPLS) is a neurological condition often associated with hypertension, eclampsia, or autoimmune diseases.
- Postpartum neurological complications require careful evaluation to differentiate various potential causes.
Observation:
- A 25-year-old female presented with headache, elevated blood pressure, and seizures 10 days postpartum.
- The patient had no history of preeclampsia-eclampsia or chronic hypertension.
Findings:
- Magnetic resonance imaging (MRI) revealed reversible vasogenic edema in the posterior white matter, characteristic of RPLS.
- The clinical presentation and imaging findings confirmed RPLS in the postpartum period.
Implications:
- This case highlights that RPLS can manifest postpartum even without preeclampsia-eclampsia or chronic hypertension.
- Prompt recognition and aggressive management, including seizure and blood pressure control, are vital to prevent ischemic complications and improve patient prognosis.
- Clinicians should maintain a high index of suspicion for RPLS in postpartum women presenting with seizures and neurological deficits.
Related Concept Videos
Encephalitis l: Introduction
Hepatic Encephalopathy
Cerebral Edema ll: Pathophysiology
Encephalitis ll: Pathophysiology
Brain Abscess l: Introduction
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...

